• 제목/요약/키워드: Lymphomatoid granulomatosis

검색결과 4건 처리시간 0.022초

Low Grade Pulmonary Lymphomatoid Granulomatosis with an Endobronchial Mass

  • Kim, Kyung Hoon;Park, Jinhee;Yoo, Ji Yeon;Kim, Min Jae;Kim, Il;Rhee, Chin Kook;Lee, Hea Yon
    • Tuberculosis and Respiratory Diseases
    • /
    • 제78권2호
    • /
    • pp.137-141
    • /
    • 2015
  • Lymphomatoid granulomatosis (LYG) is an angiocentric and angiodestructive neoplastic proliferation of B and T lymphocytes commonly involving the lungs. Epstein-Barr virus is commonly detected in lesional cells. We report a case of a 54-year-old female with underlying monoclonal gammopathy of unknown significance who presented with a 4 week history of dyspnea and cough. Computed tomography scan of the chest showed multiple lung nodules as well as endobronchial narrowing causing atelectasis at the left upper lobe. Bronchoscopic findings revealed obstruction at the lingula segment due to endobronchial mass as a rare presentation. Bronchoscopic biopsy was diagnosed with LYG grade 1. After treatment, the endobronchial mass and lung lesions were completely resolved. However, the patient eventually evolved to malignant lymphoma after 1 year.

소아 환자의 폐와 뇌에 발생한 림프종모양육아종증: 증례 보고 (Lymphomatoid Granulomatosis Involving the Lung and Brain in a Child: A Case Report)

  • 황숙민;유소영;김지혜;전태연;오세린;조은윤;제보경
    • 대한영상의학회지
    • /
    • 제82권1호
    • /
    • pp.267-273
    • /
    • 2021
  • 림프종모양육아종증은 드문 B 세포형 림프세포증식병으로 추후 림프종으로 발전할 수 있는 높은 치사율을 가진 질병이다. 이는 주로 폐를 침범하며, 흔하진 않지만 뇌, 피부에도 발병할 수 있다. 소아 환자에서 림프종모양육아종증은 매우 드물게 보고된 질병으로 영상의학적 소견의 보고 또한 매우 적다. 저자들은 소아 환자에서 폐와 뇌에서 발병한 림프종모양육아종증 증례와 이의 특징적 영상의학적 소견에 대해 보고하고자 한다.

Pulmonary Lymphomatoid Granulomatosis in a Cocker Spaniel

  • Kang, Byeong-Teck;Park, Chul;Jung, Dong-In;Kim, Ha-Jung;Kim, Ju-Won;Lim, Chae-Young;Ko, Ki-Jin;Lee, So-Young;Cho, Sue-Kyung;Gu, Su-Hyun;Park, Hyo-Jin;Jeon, Hyo-Won;Sung, Ju-Heon;Youn, A-Ram;Kim, Jung-Hyun;Han, Sung-Kuk;Sur, Jung-Hyang;Chung, Byung-Hyun;Park, Hee-Myung
    • 한국임상수의학회:학술대회논문집
    • /
    • 한국임상수의학회 2006년도 춘계학술대회
    • /
    • pp.154-154
    • /
    • 2006
  • PDF

코의 Angiocentric Immunoproliferative Lesions(AILs) (Angiocentric Immunoproliferative Lesions(AILs) in Nose)

  • 한지연;김재유;이연수;정수미;김민식;윤세철;김훈교;조승호;김병기;이경식;김동집
    • 대한두경부종양학회지
    • /
    • 제12권1호
    • /
    • pp.16-21
    • /
    • 1996
  • Lymphomatoid granulomatosis, polymorphic reticulosis, midline malignant reticulosis, or lethal midline granuloma have similar histologic features of an angiocentric and angiodestructive lymphoreticular proliferation representing the same nosologic entity. The term 'angiocentric immunoproliferative lesion' (AIL) was proposed by Jaffe, Costa, and Martin. The malignant potential of AILs is originally uncertain, but the facts that AILs have a relatively short survival, and most of them usually progress to an overt malignant lymphoma and survival is inversely proportional to the large, atypical lymphoreticular cells suggest that AILs are malignane. We experienced 17 AILs in nose during 16-year period and retrogradely analized them to recognize the problems in the diagnosis and to establish the further therapeutic strategies. The results were as follows; Twelve of total 17 patients who had diagnosed as histologic grade 1 and 2 had received radiation therapy as an initial treatment and the complete response rate was 91.7%(11/12), but 6 out of 11 had local recurrence and 5 had progress to overt maligant lymphoma within 2years. Three patients with the histologic grade 3 and 2 with unclear histologic grade had received CHOP chemotherapy and there was 1 case with complete response. Two patients with unclear histologic grade had been proved to be malignant histiocytosis by bone marrow biopsy during the clinical course. The overall duration of survival was 2 - 119 months and the 5-year survival rate was 71.9%. And the achievement of initial complete response was the most important prognostic factor of overall survival(P=0.006). Our results suggest that the treatment strategy according to the histologic grading scheme is efficient and more aggressive combination chemotherapy may be necessary to achieve complete response in patients with histologic grade III and II, because most of them progress to overt malignant lymphoma during its process.

  • PDF